☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Euretina 2021
Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar- ranibizumab) for the Treatment of nA...
September 10, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.